癌ゲノムからの洞察を臨床実践に翻訳する
1Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA. lynda_chin@dfci.harvard.edu
Nature
|April 4, 2008
まとめ
癌細胞には様々な遺伝的,表遺伝的変化があります. 将来の研究は,これらの変化をマッピングし,背景の騒音から因果的要因を区別し,がん医学を改善することを目指しています.
科学分野:
- 腫瘍学 腫瘍学
- ゲノミクスゲノミクスとは
- エピジェネティクス エピジェネティクス
背景:
- 癌細胞は,有意な遺伝的逸脱と表遺伝的変異を呈している.
- 先進的な技術は,がんにおけるゲノム変化の詳細なカタログ化を可能にします.
- がん特異的な変異の包括的なアトラスが予想されています.
研究 の 目的:
- 癌を誘発する分子異常と,ゲノム/エピゲノム背景の"騒音"を区別する.
- 癌の病理生理学を駆動する偏差の共同メカニズムを理解する.
- 癌医学における臨床応用のためのゲノム学的洞察を活用する.
主な方法:
- 詳細なゲノムカタログ作成のための強力なテクノロジーを活用します.
- 癌細胞における遺伝的逸脱と表遺伝的改変を分析する.
- ゲノムの発見を臨床的ツールに変換する過去の成功をレビューする.
主要な成果:
- 遺伝的および表遺伝的変化による癌細胞の多様な生物学的能力の識別.
- 課題は,原因となる分子異常を,貢献しない変化から区別することにある.
- ゲノムの発見を臨床的ツールに成功裏に翻訳することは,将来の応用のためのモデルを提供します.
結論:
- 機能的なゲノム変異をノイズから区別することは,がんを理解するために不可欠です.
- 協同的な偏差メカニズムを理解することは,がんの病理生理学的洞察を前進させるでしょう.
- ゲノムの洞察を臨床実践に翻訳することは,がん医学にとって大きな可能性を秘めています.
さらに関連する動画
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
関連する概念動画
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...